Hell work with you to find the best treatment for your anti-aging goals
Staying informed and having open communication with your medical provider can help ensure you have a safe treatment
Eli Lillys triple agonist, retatrutide, demonstrated an average weight loss of 16.8% in a Phase 3 trial for the treatment of type 2 diabetes, the company announced today
The manufacturer would then need to submit an application to the FDA
A practical rotation schedule: abdomen during weeks 1-4, upper thigh during weeks 5-8, upper arm during weeks 9-12, then back to abdomen for maintenance
GLOW is a research peptide blend combining BPC-157, TB-500, and GHK-Cu in a single lyophilized vial